The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to scale down manufacturing amid weakening demand for its COVID-19 vaccine. The company ...
Shares of vaccine maker Moderna dropped more than 5% late Wednesday after reports that the Health and Human Services ...
According to HHS, Moderna’s bird flu vaccine candidate uses the same mRNA technology that was used during the COVID-19 response, resulting in one of the first FDA-authorized COVID vaccines.
Moderna has been banking on revenue from newer mRNA shots to make up for waning post-pandemic demand for COVID-19 vaccines and less-than-expected uptake of its respiratory syncytial virus vaccine ...
American pharmaceutical company Moderna (MRNA) is reportedly under scrutiny by U.S. President Donald Trump’s team, which is ...
The U.S. government awarded Moderna $590 million in January to advance the development of its bird flu vaccine ...